Dr. Brentnall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-598-4477Fax+1 206-598-4303
Summary
- I am a board certified GI doctor who specializes in the early detection of GI cancers of high-risk individuals. I see high-risk patients in a multi-disciplinary clinic and provide global recommendation for endoscopic surveillance, genetics evaluation, and cancer prevention.
Education & Training
- University of WashingtonFellowship, Gastroenterology, 1991 - 1994
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1987 - 1990
- University of Washington School of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 1988 - Present
- WA State Medical License 1991 - 2026
Publications & Presentations
PubMed
- 188 citationsMass spectrometry based glycoproteomics - from a proteomics perspectiveSheng Pan, Ru Chen, Ruedi Aebersold, Teresa A. Brentnall
Molecular & Cellular Proteomics. 2011-01-01 - 111 citationsCost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindredsStephen J. Rulyak, Michael B. Kimmey, David L. Veenstra, Teresa A. Brentnall
Gastrointestinal Endoscopy. 2003-01-01 - 104 citationsScreening and surveillance for hereditary pancreatic cancerMichael B. Kimmey, Mary P. Bronner, David R. Byrd, Teresa A. Brentnall
Gastrointestinal Endoscopy. 2002-10-01
Grant Support
- Aberrant Glycosylation Signature In Pancreatic CancerNational Cancer Institute2011–2012
- Development Of Chronic Pancreatitis BiomarkersNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Pancreatic Cancer Protein Biomarkers For Early DetectionNational Cancer Institute2006–2010
- Biomarkers Of UC TumorigenesisNational Cancer Institute2006–2010
- Histologic And Molecular Changes In UC TumorigenesisNational Cancer Institute2000–2004
- Oxidative DNA Damage In Ulcerative Colitis TumorigenesisNational Cancer Institute1998–2002
- Predicting Progression To Dysplasia--Ulcerative ColitisNational Cancer Institute1995–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: